Register | Login

black6humor | Voted

Le survivals [24]. Similar results were obtained by immunofluorenscence-based and quantitative approach in Rimm's group from Yale University School of Medicine, a better prognosis in ALDH1(+) patients with non-small cell lung cancer, using the same primary antibody with us [39]. Thus, the choice of antibody may potentially explain the variably predictive and prognostic role of ALDH1 in human epit
An carcinoma, but the expression levels had no associations with the clinical parameters, and it is not associated with survival probabilities, which was in accordance with the findings from Woodward et al. [43] and Ohi et al. [44]. The current study has several limitations. First of all, although Allred scoring system combines the percentage and intensity of positive cells, as a manual scoring s
Icine, Faculty of Medicine, University of Oslo, Oslo, Norway. 3Departments of Gynaecology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4Departments of Gynaecology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Received: 27 January 2015 Accepted: 25 JuneReferences 1. Eskander RN, Tewari KS. Incorporation of anti-angiogenesis thera
Icine, Faculty of Medicine, University of Oslo, Oslo, Norway. 3Departments of Gynaecology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4Departments of Gynaecology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Received: 27 January 2015 Accepted: 25 JuneReferences 1. Eskander RN, Tewari KS. Incorporation of anti-angiogenesis thera
Icine, Faculty of Medicine, University of Oslo, Oslo, Norway. 3Departments of Gynaecology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4Departments of Gynaecology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Received: 27 January 2015 Accepted: 25 JuneReferences 1. Eskander RN, Tewari KS. Incorporation of anti-angiogenesis thera
Icine, Faculty of Medicine, University of Oslo, Oslo, Norway. 3Departments of Gynaecology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4Departments of Gynaecology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Received: 27 January 2015 Accepted: 25 JuneReferences 1. Eskander RN, Tewari KS. Incorporation of anti-angiogenesis thera
A badly reported 1950s trial of a vaccine similar to adsorbed anthrax vaccine (AVA). This vaccine was probably effective against cutaneous anthrax but the researchers specifically concluded that no such claims could be made regarding inhalation anthrax. The Institute of Medicine report cited by Winkenwerder and Grabenstein concludes that such evidence exists as follows: "Finding: The committee fi
Owever, there were other studies indicating a better clinical outcome in ALDH1(+) cancer patients, using different antibodies. Our previous study, using rabbit polyclonal antibody against human ALDH1A1 (ab63026, Abcam, Cambridge, UK) has proved that ALDH1 expression in vulvar squamous cell carcinomas predicted a significantly better survival than the ALDH1 negative cases [28]. Similarly, Hessman
Cuentanos tu Historia